From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 30 March

Jessica Amir
March 30, 2021

Morning Bell 29 March

Bell Direct
March 29, 2021

Weekly Wrap 26 March

Jessica Amir
March 26, 2021

Morning Bell 26 March

Jessica Amir
March 26, 2021

Morning Bell 25 March

Jessica Amir
March 25, 2021

Morning Bell 24 March

Jessica Amir
March 24, 2021

Morning Bell 23 March

Jessica Amir
March 23, 2021

Morning Bell 22 March

Jessica Amir
March 22, 2021

Weekly Wrap 19 March

Jessica Amir
March 19, 2021

Morning Bell 19 March

Jessica Amir
March 19, 2021

Morning Bell 18 March

Jessica Amir
March 18, 2021

Morning Bell 17 March

Jessica Amir
March 17, 2021